Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.05
-0.38 (-3.06%)
Apr 9, 2026, 3:04 PM CST

SHE:301211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
447.66543.211,6941,8581,860
Trading Asset Securities
1,1071,094129.4103.98-
Cash & Short-Term Investments
1,5551,6371,8241,9621,860
Cash Growth
-5.00%-10.26%-7.05%5.50%438.28%
Accounts Receivable
91.4775.5375.08127.47161.05
Other Receivables
4.153.82.661.353.09
Receivables
95.6279.3377.74128.82164.14
Inventory
122.68137.85173.8114.789.5
Other Current Assets
18.3720.6723.5921.2115.67
Total Current Assets
1,7921,8752,0992,2272,129
Property, Plant & Equipment
525.89527.75361.99184.8131.7
Long-Term Investments
10.389.64---
Other Intangible Assets
66.8368.9471.0773.2766.67
Long-Term Deferred Tax Assets
2.362.052.192.391.52
Long-Term Deferred Charges
4.381.051.33--
Other Long-Term Assets
0.434.6111.0311.471.24
Total Assets
2,4022,4892,5472,4992,330
Accounts Payable
72.27116.04117.7182.6236.13
Accrued Expenses
13.4314.9912.9211.648.86
Current Portion of Long-Term Debt
1.13----
Current Portion of Leases
-1.591.510.97-
Current Income Taxes Payable
4.663.1314.2718.1412.84
Current Unearned Revenue
9.1511.8715.0169.726.34
Other Current Liabilities
13.916.7613.7325.8238.84
Total Current Liabilities
114.55164.38175.14208.91103.01
Long-Term Leases
2.013.625.156.43-
Long-Term Unearned Revenue
1.962.042.10.220.28
Long-Term Deferred Tax Liabilities
10.138.927.496.74.24
Total Liabilities
128.65178.97189.89222.26107.53
Common Stock
417.6288288240240
Additional Paid-In Capital
1,6271,7571,7571,8051,805
Retained Earnings
228.39265.48312.17232.06178.26
Comprehensive Income & Other
0.33-0.3---
Total Common Equity
2,2732,3102,3572,2772,223
Shareholders' Equity
2,2732,3102,3572,2772,223
Total Liabilities & Equity
2,4022,4892,5472,4992,330
Total Debt
3.135.226.667.4-
Net Cash (Debt)
1,5521,6321,8171,9551,860
Net Cash Growth
-4.89%-10.21%-7.04%5.10%438.28%
Net Cash Per Share
3.563.934.344.715.97
Filing Date Shares Outstanding
489.53417.6417.6417.6417.6
Total Common Shares Outstanding
489.53417.6417.6417.6417.6
Working Capital
1,6771,7101,9242,0182,026
Book Value Per Share
4.645.535.645.455.32
Tangible Book Value
2,2062,2412,2862,2032,156
Tangible Book Value Per Share
4.515.375.475.285.16
Buildings
-257.27114.69107.54103.36
Machinery
-405.47185.73180.96173.8
Construction In Progress
-53.5228.7751.562.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.